The TIM Company is a CRO based in the Netherlands, utilizing its highly biopredictive in vitro technology to offer a range of services addressing the most challenging formulation issues. With settings ranging from healthy adults, disease conditions, fasted/fed, and PPI conditions, we are able to simulate and alter each physiologically relevant parameter of the human GI tract. With expertise built over 25 years, and trusted relationships with industry, TIM Studies represent a unique asset in your drug development process. From formulation ranking, to food-effect, to microbiome studies, we’ll design your TIM study to provide valuable insights into your formulation performance & accelerate your drug development timelines.